Practices
Needle and Syringe Programmes
Also Known As NSP · Needle Exchange · Syringe Services Programs
Harm Reduction Practice
Citation Formats
General Reference
APA Style
BibTeX
A harm reduction practice that provides sterile injecting equipment to people who inject drugs, through fixed sites, outreach and other delivery models. The WHO, UNAIDS and UNODC operational guide describes the programmes as a core harm reduction intervention, highly effective in preventing HIV and hepatitis C transmission, reducing skin and soft tissue infections, and providing an entry point for overdose prevention and broader health support. High-coverage provision of needles and syringes in Europe has been associated with a 76 percent reduction in hepatitis C acquisition. WHO first recommended the programmes for HIV prevention in 2003; the guide is frank that coverage remains inadequate in most countries and that criminalization and stigmatization are persistent barriers, so the practice remains contested policy territory in many places.
Facts
Origin YearThe year WHO first recommended needle and syringe programmes for HIV prevention; the earliest programmes themselves predate the recommendation. Practice ClassPublic health, harm reduction 1 Cross-Tradition Connections
Sources
1. Needle and Syringe Programmes for People Who Inject Drugs: Operational Guide
World Health Organization, 2025Summary, page ixQuote, Summary, page ix
Needle and syringe programmes (NSPs) are often the first point of contact with marginalized people who inject drugs. As a core intervention for harm reduction, they are highly effective in preventing HIV and HCV transmission, reducing the incidence of skin and soft tissue infections and providing an entry point for prevention of overdoses and broader health support.
View the Source 1. Needle and Syringe Programmes for People Who Inject Drugs: Operational Guide
World Health Organization, 2025Summary, page ix, HCV evidenceQuote, Summary, page ix, HCV evidence
In Europe, high-coverage provision of needles and syringes has been associated with a 76% reduction in HCV acquisition.
View the Source 1. Needle and Syringe Programmes for People Who Inject Drugs: Operational Guide
World Health Organization, 2025Section 1, Core interventions, page 3Quote, Section 1, Core interventions, page 3
WHO first recommended NSPs for HIV prevention in 2003, providing the basis for their formal recognition as an essential harm reduction intervention.
View the Source 1. Needle and Syringe Programmes for People Who Inject Drugs: Operational Guide
World Health Organization, 2025In Branch: Public Health, Summary, harm reduction framingView the Source Reader Challenges (0 open reader challenges)
No disputes yet. Spotted an error or a better source? Open the first one.
Sign in to dispute this or suggest a correction.
View At A Past Year
The atlas records no dated fact of its own for this entry, so there is no other year to choose.